2025 third_quarter Filing
Q3Lobbying Activities
Medication affordability and access; general diabetes prevention, 340B, monitoring FDA reform, changes and new programs.
Support for obesity drug coverage and access.
Treat and Reduce Obesity Act; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169) implementation. Pharmacy benefit manager reform proposals. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.